Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1900 (LINC01900) is a long intergenic non-coding RNA (lincRNA), meaning it is a >200 nucleotide transcript that does not overlap protein-coding regions and is not translated into protein. lincRNAs, including LINC01900, typically regulate gene expression at the epigenetic, transcriptional, or post-transcriptional level and can fine-tune genes in a tissue- or context-specific manner. LINC01900 itself has no known direct coding potential or established therapeutic relevance. It was identified in a novel gene fusion (LYN::LINC01900) associated with a rare subtype of acute myeloid leukemia that carried a TP53 mutation, but the biological significance of this fusion remains to be established. LINC01900 is not considered a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1900 (LINC01900).